Pharmacokinetics, and Efficacy of S-033188 after Administration of a Single Dose to Otherwise Healthy Pediatric Patients Aged 6 Months to < 12 Years with Influenza. [Internet; cited 2019 June]. Available from: https://rct...
Find information for HCPs about XOFLUZA® (baloxavir marboxil), a single-dose oral antiviral treatment for influenza. See full safety for more information.
Usual Adult Dose for Influenza Prophylaxis: 20 kg to less than 80 kg: 40 mg orally once as a single dose At least 80 kg: 80 mg orally once as a single dose Use: -For postexposure prophylaxis of influenza after contact with an individual who has influenza ...
Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription medicine flu treatment that attacks the flu virus at its source. See full safety for more information.
An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of S-033188 after Administration of a Single Dose to Otherwise Healthy Pediatric Patients Aged 6 Months to < 12 Years with Influenza. [Internet; cited 2019 June]. Available from: /en/detail?trial_id=Japic...
Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription medicine flu treatment that attacks the flu virus at its source. See full safety for more information.
Xofluza is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy in a wide range of influenza viruses, including in vitro activity against oseltamivir-resistant ...
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu –The MINISTONE-2 study showed XOFLUZA, given as a new oral suspension, is a well-tolerated and effective potential treatment for the flu in ...
[1]Shionogi,Roche get their first approval for the next big thing in fighting the flu [2]Baloxavir Marboxil Demonstrates Positive Phase 3 Influenza Results [3]Single-dose flu drug approved for sale in Japan [4]New Drugs Are Coming to Fight Nasty Flu Seasons...
[5] Baker J, et al. Single-dose baloxavir marboxil for the treatment of influenza in otherwise-healthy children aged 1 to <12 years (miniSTONE-2). Presented at: OPTIONS X; 2019 August 28-September 1; Singapore. Abstract #11756. ...